638
Views
3
CrossRef citations to date
0
Altmetric
CASE SERIES

Case Series of HIV-Associated Oral Lesions Among Antiretroviral-Naive Patients During the COVID-19 Pandemic

ORCID Icon & ORCID Icon
Pages 73-82 | Received 08 Dec 2022, Accepted 20 Jan 2023, Published online: 30 Jan 2023

References

  • Riedel S, Morse S, Mietzner T, Miller S. Jawetz Melnick & Adelbergs Medical Microbiology 28 E Medical Microbiology. McGraw Hill Professional; 2019.
  • Deeks SG, Overbaugh J, Phillips A, Buchbinder S. HIV infection. Nat Rev Dis Prim. 2015;1:1–22. doi:10.1038/nrdp.2015.35
  • Lomelí-Martínez SM, González-Hernández LA, Ruiz-Anaya AD, et al. Oral manifestations associated with HIV/AIDS patients. Medicina. 2022;58:1214. doi:10.3390/medicina58091214
  • Berberi A, Aoun G. Oral lesions associated with human immunodeficiency virus in 75 adult patients: a clinical study. J Korean Assoc Oral Maxillofac Surg. 2017;43:388. doi:10.5125/jkaoms.2017.43.6.388
  • Aškinytė D, Matulionytė R, Rimkevičius A. Oral manifestations of HIV disease: a review. Stomatologija. 2015;17:21–28.
  • Bajpai S. Oral manifestations of HIV disease. Contemp Clin Dent. 2010;1:1–5. doi:10.4103/0976-237X.62510
  • Sürme Y, Özmen N, Ertürk Arik B. Fear of COVID-19 and related factors in emergency department patients. Int J Ment Health Addict. 2021. doi:10.1007/s11469-021-00575-2
  • Jumadi J, Fikriyah VN, Hadibasyir HZ, et al. Spatiotemporal accessibility of COVID-19 healthcare facilities in Jakarta, Indonesia. Sustainability. 2022;14(21):14478. doi:10.3390/su142114478
  • Mahendradhata Y, Andayani NL, Hasri ET, et al. The capacity of the Indonesian healthcare system to respond to COVID-19. Front Public Health. 2021;9:1–9. doi:10.3389/fpubh.2021.649819
  • Sufiawati I, Rafi MA, Putri FM. Evaluating knowledge, attitude, and behavior of dentists on HIV/AIDS in West Java, Indonesia, in the COVID-19 era. Int J Dent. 2021;2021. doi:10.1155/2021/1901887
  • Santella AJ, Conway DI, Watt RG. The potential role of dentists in HIV screening. Br Dent J. 2016;220:229–233. doi:10.1038/sj.bdj.2016.172
  • Tappuni AR, Sufiawati I. The Bali declaration on oral health in HIV/AIDS. Oral Dis. 2020;26(S1):172. doi:10.1111/odi.13404
  • Noujeim Z, Mantash A, El-Outa A, Doumit M. Oral manifestations of HIV infection and aids: an update on clinical diagnosis and management. Int J Cur Adv Res. 2017;6:6256–6263. doi:10.24327/ijcar.2017.6263.0905
  • Boasso A, Shearer GM, Chougnet C. Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? J Intern Med. 2009;265(1):78–96. doi:10.1111/j.1365-2796.2008.02043.x
  • HIkmah N. Kejadian Hiv/Aids dengan manifestasi oral pada anak-anak. Stomatognatic. 2010;7(1):20, 68–73.
  • de Paulo LFB, Servato JPS, Oliveira MTF, Durighetto AF, Zanetta-Barbosa D. Oral manifestations of secondary syphilis. Int J Infect Dis. 2015;35:40–42. doi:10.1016/j.ijid.2015.04.007
  • Feller L, Chandran R, Marnewick JC, et al. Syphilis in the context of HIV infection. SADJ. 2011;66(6):288–291.
  • Chadwick DR, Sutherland RK, Raffe S, Pool ERM, Beadsworth MBJ. British HIV association guidelines on the management of opportunistic infection in people living with HIV: the clinical management of candidiasis 2019. HIV Med. 2020;21(S5):1–19. doi:10.1111/hiv.13004
  • Lestari PE. Infeksi jamur candida pada penderita Hiv/Aids. J Kedokt Gigi Unej. 2013;10:35–38.
  • Salvatori O, Puri S, Tati S, Edgerton M. Innate immunity and saliva in candida albicans -mediated oral diseases. J Dent Res. 2016;95:365–371. doi:10.1177/0022034515625222
  • Fidel PL. Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis. Adv Dent Res. 2011;23:45–49. doi:10.1177/0022034511399284
  • Pandarathodiyil AK, Anil S, Vijayan SP. Angular cheilitis-an updated overview of the etiology, diagnosis, and management. Int J Dent Oral Sci. 2021;8:1437–1442.
  • Dowd FJ, Johnson BS. Pharmacology and Therapeutics for Dentistry. Elsevier; 2017.
  • Glick M, Greenberg MS, Lockhart PB, Challacombe SJ. Introduction to oral medicine and oral diagnosis: patient evaluation. In: Burket’s Oral Medicine. Wiley Online Library; 2021.
  • Quindos G, Gil-Alonso S, Marcos-Arias C, et al. Therapeutic tools for oral candidiasis: current and new antifungal drugs Guillermo. Med Oral Patol Oral Cir Bucal. 2019;24:e172–e180. doi:10.4317/medoral.22978
  • Trevor JA, Katzung GB. Pharmacology Examination & Board Review. McGraw Hill; 2015.
  • Lyu X, Zhao C, Yan ZM, Hua H. Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis. Drug Des Devel Ther. 2016;10:1161–1171. doi:10.2147/DDDT.S100795
  • Alpagot T, Konopka K, Bhattacharyya M, Gebremedhin S, Düzgüneş N. The association between gingival crevicular fluid TGF-β1 levels and periodontal status in HIV-1 + patients. J Periodontol. 2015;79:123–130. doi:10.1902/jop.2008.070312
  • Phiri R, Feller L, Blignaut E. The severity, extent and recurrence of necrotizing periodontal disease in relation to HIV status and CD4+ T cell count. J Int Acad Periodontol. 2014;12:98–103.
  • Peters SM, Heinz MJ, Koslovsky DA, Yoon AJ, Philipone EM. Necrotizing ulcerative stomatitis as initial presentation of undiagnosed HIV infection: a case report and review of literature. J Oral Maxillofac Surg Med Pathol. 2017;29:570–574. doi:10.1016/j.ajoms.2017.07.005
  • Menon S. Periodontal diseases in HIV. Int J Dent Sci. 2000;14:1–6.
  • Malek R, Amina G, Nadia K. Necrotizing ulcerative gingivitis abstract. Contemp Clin Dent. 2017;8:496–500. doi:10.4103/ccd.ccd_1181_16
  • Kato H, Imamura A. Unexpected acute necrotizing ulcerative gingivitis in a well-controlled hiv-infected case. Intern Med. 2017;56:2223–2227. doi:10.2169/internalmedicine.8409-16
  • Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, et al. Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther. 2014;143(2):225–245. doi:10.1016/j.pharmthera.2014.03.003
  • Kapoor A, Malhotra R, Grover V, Grover D. Systemic antibiotic therapy in periodontics. Dent Res J. 2012;9:505–515. doi:10.4103/1735-3327.104866
  • Ribas R, Lima AAS. Oral ulcers induced by cytomegalovirus infection: report on two cases. J Dent Indones. 2017;24(2):50–54. doi:10.14693/jdi.v24i2.1002
  • Whitley RJ, Jacobson MA, Friedberg DN, et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. Arch Intern Med. 1998;158:957–969. doi:10.1001/archinte.158.9.957
  • Lalonde RG, Bovivin G, Deschênes J, et al. Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS. Can J Infect Dis. 2004;15:327–335.
  • Martins LL, Rosseto JHF, Andrade NS, et al. Diagnosis of oral hairy leukoplakia: the importance of EBV in situ hybridization. Int J Dent. 2017;2017:1–6. doi:10.1155/2017/3457479
  • Greenspan JS, Greenspan D, Webster-Cyriaque J. Hairy leukoplakia; lessons learned: 30-plus years. Oral Dis. 2016;22:120–127. doi:10.1111/odi.12393
  • Alexander Kreuter MD. Oral hairy leukoplakia: a clinical indicator of immunosuppression Alexander. CMAJ. 2011;183(4):932. doi:10.1503/cmaj.100841